Not finding it? Sign in to also search OpenAlex live.
-
689P Predicting oncotype DX recurrence score using clinicopathological variables in HR-positive, HER2-negative breast cancer: A real-world analysis from an Italian breast unit2026 ESMO Open article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
P.J. Paganoni, M. Laganà, Matteo Rota, D. Cosentini, G. Mola, Greta Schivardi, +5 more
0citations -
Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?2025 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Ana-Alicia Beltran-Bless, Gregory R. Pond, Jane Bayani, Sarah L. Barker, Melanie Spears, Elizabeth Mallon, +10 more
4citations -
Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study2021 npj Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
John M.S. Bartlett, Jane Bayani, Elizabeth N. Kornaga, Keying Xu, Gregory R. Pond, Tammy Piper, +11 more
11citations -
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer2021 npj Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Jane Bayani, Coralie Poncet, Cheryl A. Crozier, Anouk Neven, Tammy Piper, Carrie Cunningham, +30 more
10citations -
Guiding treatment decisions in early breast cancer: A model-based comparison of the OncotypeDX and MammaPrint tests2026 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Frank Doornkamp, Liesbeth C. de Wreede, Elfi M. Verheul, Agnes Jager, Ewout Willem Steyerberg
0citations
6 results